B
2.71
0.04 (1.69%)
| Penutupan Terdahulu | 2.66 |
| Buka | 2.69 |
| Jumlah Dagangan | 81,892 |
| Purata Dagangan (3B) | 128,871 |
| Modal Pasaran | 129,437,776 |
| Harga / Pendapatan (P/E TTM) | 3.42 |
| Harga / Pendapatan (P/E Ke hadapan) | 6.61 |
| Harga / Jualan (P/S) | 0.490 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| Margin Keuntungan | 10.55% |
| Margin Operasi (TTM) | 19.78% |
| EPS Cair (TTM) | 0.580 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -52.10% |
| Nisbah Semasa (MRQ) | 1.42 |
| Aliran Tunai Operasi (OCF TTM) | 44.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 54.17 M |
| Pulangan Atas Aset (ROA TTM) | 16.29% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Bercampur | Bercampur | |
| Stok | Biote Corp. | Menurun | Menurun |
AISkor Stockmoo
-0.9
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.88 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 13.02% |
| % Dimiliki oleh Institusi | 65.98% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Nov 2025 | Pengumuman | Biote Reports Third Quarter 2025 Financial Results |
| 22 Oct 2025 | Pengumuman | Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |